Charlie Banana is an eco-friendly, reusable cloth diaper and personal care brand founded in 2010 by Gaëlle Wizenberg. Initially created to serve Hong Kong babies with high-quality, sustainable products, the brand has since grown into an international name once marketed in 66 countries. Now owned by a Hong Kong-based company, Charlie Banana offers a range of baby care and feminine hygiene products. Charlie Banana’s mission is to create premium reusable cloth diapers, swim diapers, training pants, rash guards and wipes that are ultra-soft against baby’s delicate skin. Our award-winning products, made with selected materials, clever design features, and joyful prints, are a smart investment and a stylish alternative to single-use baby products. At Charlie Banana, we are deeply committed to sustainable development. We believe in creating products that not only care for your baby but also for the planet. Our reusable cloth diapers and eco-friendly accessories are designed with the environment in mind, using responsibly sourced materials and innovative practices. We strive to minimize our ecological footprint while promoting a healthier, more sustainable future for generations to come. Through continuous improvement and community engagement, we aim to inspire others to join us on this journey towards a greener world. Every Charlie Banana purchase directly benefits the planet.
Centre for Virology, Vaccinology and Therapeutics
The Centre for Virology, Vaccinology, and Therapeutics (CVVT), established in 2020 with the University of Hong Kong, is dedicated to reducing the health and economic impacts of future outbreaks. By pioneering rapid diagnostics, potent antimicrobials, and advanced vaccines, CVVT tackles endemic diseases in peacetime and prepares the world for epidemics and pandemics. Serving as a crucial bridge between foundational research and transformative technologies, CVVT cultivates a dynamic startup ecosystem focused on innovative solutions for infectious diseases and global health advancements. At this exhibition, discover our innovative startups: • Orimmune BioTech Limited, introducing its revolutionary Δ42PD1-specific antibody drug, set to redefine cancer immunotherapy with a novel immune-modulatory approach. • Antenovus Biotechnology Limited, combating antimicrobial resistance (AMR) with antivirulence therapies and antibiotic adjuvants targeting pathogens like MRSA. • Hong Kong Universal Vaccine Limited, unveiling its next-generation inhaled powder vaccine for children and elderly, offering needle-free mucosal immunity against influenza, COVID, and RSV. • BiomOrgan Limited, showcasing the world’s first human respiratory organoid culture system, transforming drug development and virus research. Visit our booth to explore how CVVT converts visionary research into practical solutions, enhancing global health resilience and positioning Hong Kong as a biotechnology hub against emerging infectious threats.
Centre for Translational Stem Cell Biology
Centre for Translational Stem Cell Biology (CTSCB) provides Hong Kong with an opportunity to excel in scientific and medical research. A team of top-notch scientists and clinicians from the University of Hong Kong and the University of Cambridge collaborates to elevate stem cell technology to new heights. By leveraging a pioneering patented technology, Expanded Potential Stem Cells (EPSCs), CTSCB is dedicated to advancing fundamental research and translating discoveries into regenerative medicine, organ transplantation and genomic medicine for the benefit of people worldwide. CTSCB primarily focuses on producing mature and functional cells for regenerative medicine with the patented technology, enabling in-depth study of immune disease mechanism, and expediting the development of antiviral, anti-ageing natural products and antibody drugs. Our vision is to translate medical discoveries and homegrown technologies into applications that not only serve medical and biotechnological purposes but also extend to the agricultural sector, fostering the growth of innovation and technology. | Imagine a future where healthcare is transformed by cutting-edge stem cell technology. Centre for Translational Stem Cell Biology (CTSCB), a collaboration between the University of Hong Kong and the University of Cambridge, supported by the Innovation and Technology Commission, is at the forefront of making this vision a reality. Leveraging patented Expanded Potential Stem Cell (EPSC) technology, we can create any cell type, both embryonic and extra-embryonic, offering immense potential for regenerative medicine and therapeutic applications. Our research focuses on intelligent drug screening, precision medicine and cell-based therapies. We develop next-generation stem cell technology that improves patient outcomes and enhances quality of life. Our drug screening platforms support pharmaceutical and health supplement companies in streamlining their development processes using multicellular organoid systems and personalized disease modelling. We also explore health and cosmetic products derived from EPSC technology, with interests in product co-development to address various health issues. By attracting top global talent and fostering innovation, CTSCB is well-positioned to enhance therapeutic applications and promote longevity. Through our innovative research and commitment to excellence, CTSCB aims to lead the way in revolutionary healthcare solutions for generations to come.
CASETiFY
CASETiFY is a renowned global lifestyle brand that specializes in providing customizable tech accessories. CASETiFY is more than just a brand; it is a lifestyle. Join us in our mission to protect what matters most while expressing your unique style.
Cameron Sino Technology Ltd.
Cameron Sino Technology Limited was established in Hong Kong in 2000, focusing on developing the latest and most powerful batteries. We provide a wide range of batteries for various industries, with more than 20,000 battery types. Our company integrates R&D, production and sales.
Byond Digital
BYOND Digital is a next-generation AI company building hyper-realistic digital human solutions that combine patented hardware, advanced AI software, and authentic personas to transform the way humans interact with technology. Our mission is to bring AI out of the screen and into the real world, where it can solve real challenges – helping people save time, helping organizations save money, and creating new commercial value.